SET CONTAINING ONE IMPLANTATION ACCESSORY AND ONE IMPLANTABLE FLEXIBLE STIMULATION PROBE

DE602021021523T2Active Publication Date: 2024-11-06SORIN CRM
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602021021523
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-10-15
Filing Date
2021-10-15
Publication Date
2024-11-06
Estimated Expiration
2041-10-15

AI Technical Summary

Technical Problem

Epicardial probes for cardiac stimulation have invasive implantation methods and poor electrical performance compared to endocardial probes, leading to reduced effectiveness and increased tissue trauma.

Method used

A flexible implantable stimulation probe assembly with a needle and probe body, featuring a first branch and second portion that pivot to secure the probe against the heart wall, allowing for improved electrical contact and reduced invasiveness through a hollow needle, with optional electrodes placed within the heart wall for enhanced stimulation.

Benefits of technology

The solution enhances the effectiveness of cardiac stimulation by improving electrical performance and reducing the invasive nature of the implantation process, allowing for better retention and easier removal of the probe with minimal tissue damage.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

Domaine technique

[0001] The present invention relates to an assembly of an implantation accessory and an implantable flexible stimulation probe for an active implantable medical device. Arrière-plan technique

[0002] It is known to stimulate the right ventricle by placing a so-called endocardial probe in the right ventricle of the heart where it is introduced via the venous network, or by means of a so-called endocavitary probe implanted in the cavities via venous access.

[0003] It is also known to use so-called epicardial probes, which are directly attached to the outer wall of the myocardium. However, an epicardial probe often provides poorer results than those obtained using an endocardial probe, particularly in terms of electrical performance.

[0004] In addition, it is known to hold epicardial leads to the epicardium wall by suturing or screwing in a helical screw to anchor the lead, but these mechanical fixations have the disadvantage of being invasive and relatively traumatic for the tissues.

[0005] Thus, the most significant disadvantage of known epicardial probes is the invasive side of the intervention compared to endocavitary probes.

[0006] Furthermore, besides the invasive nature of their implantation, another common drawback of these known epicardial probes is their poor electrical performance, which is detrimental to the effectiveness of stimulation.

[0007] US-A1-2005 / 136385 discloses a cardiac rhythm management apparatus comprising a proximal housing, a distal housing and a lead. The proximal housing comprises a first energy storage device. The distal module is implantable in a patient's heart and comprises a second energy storage device, at least one electrode and a control module. The control module controls the delivery of at least one electrical stimulus from the second energy storage device to a location in communication with the patient's heart. The lead connects the proximal housing to the distal module and is configured to communicate one or more digital signals between the proximal housing and the distal module.

[0008] US-A1-2015 / 320330 discloses electrical sensing / stimulation devices for positioning at least one electrode in body tissue. An electrical sensing / stimulation device may include an elongated lead body having at least one internal lumen, at least one sensing / stimulation electrode, an expandable / retractable displacement member that moves or biases at least one electrode toward a direction presented by the user, a tissue fixation mechanism for securing the distal segment of the device to body tissue, and an atraumatic distal lead body termination.

[0009] US-A1-2015 / 157268 discloses systems, devices and methods for anchoring implants in the human body, and more specifically retention means for securing in a cardiac chamber a sensory implant comprising an elongated body enclosing a lumen and a sensory element disposed therein, a proximal retention element coupled to said elongated body and comprising a plurality of protrusions, and a distal retention element positioned distally of said proximal retention element and coupled to said elongated body. Description de l'invention

[0010] The invention is defined in claim 1. Other aspects and preferred embodiments are defined in the appended claims. Aspects, embodiments and examples of the present disclosure which do not fall within the scope of the appended claims do not form part of the invention and are provided merely for illustration.

[0011] The invention aims to overcome the various limitations set out above, by proposing a stimulation probe making it possible to improve the effectiveness of the stimulation while reducing the invasive nature of its implantation.

[0012] The object of the present invention is achieved by means of a set of an implantation accessory and an implantable flexible stimulation probe. Said probe comprises a probe body, and is capable of being combined with an active implantable medical device via its proximal end and is configured to be implanted through a wall of the heart, in particular through the free wall of the right ventricle, via its distal end. The implantation accessory comprises a needle with a sharp free puncture end, the needle being at least in its distal part a hollow needle comprising an internal lumen opening onto the sharp free puncture end, at least a first portion of the probe being capable of being inserted via its distal end into the internal lumen of the needle.In a state where the first portion of the probe is inserted into the lumen of the needle, said first portion of the probe comprises at least a first branch which extends from the probe body in a direction oriented towards the sharp free end of the needle, the first branch extending from the probe body from a junction point disposed at a predetermined distance from the distal end forming a second portion of the probe body between the junction point of the first branch and the distal end of the probe.

[0013] Thus, the needle allows the wall of the right ventricle of the heart to be punctured and the probe to be inserted therein. The probe comprising at its distal end a first branch and a second portion of the probe body, said probe is thus provided with a retaining means when the probe is implanted through the free wall of the right ventricle. This means for retaining the probe is insertable into the needle by means of which it can be implanted into the cardiac tissue.

[0014] The probe being implantable through the free wall of the right ventricle, the first branch and the second portion of the probe body can be arranged in the right ventricle, in particular against the internal wall.

[0015] The present invention, relating to a set of an implantation accessory and an implantable flexible stimulation probe, can be further improved by the following embodiments.

[0016] The probe body further comprises a third portion less rigid than said first branch and the second portion, the third portion extending towards the proximal end of the probe from the junction point of the first branch, such that the first branch and the second portion are configured to pivot integrally with each other relative to said junction point.

[0017] Thus, the first branch and the second portion are made integral with each other during a pivoting movement around the junction point. This pivoting makes it possible to position the means for retaining the probe against the internal wall of the right ventricle in an implanted state of the probe.

[0018] According to one embodiment, in a state where the first portion of the probe is inserted into the lumen of the needle, the first branch and the second portion may form an obtuse angle and the first branch and the third portion may form an acute angle.

[0019] Thus, the first branch is arranged so as to be able to provide a means of retention in an implanted state of the probe following the integral pivoting of the first branch and the second portion relative to the junction point.

[0020] According to one embodiment, the first branch and / or the second portion may comprise at least one electrode.

[0021] Thus, in an implanted state of the probe, the at least one electrode, in particular the anode, can be arranged on the inner wall of the right ventricle. As a result, thanks to the direct contact of the anode with the heart wall, stimulation can be improved.

[0022] According to one embodiment, the probe body may comprise at least one electrode which is spaced from the junction point of the probe by a length of between 2 and 50 mm, in particular between 2 and 30 mm.

[0023] Thus, these dimensions allow, in an implanted state of the probe, to arrange at least one electrode, in particular the cathode, in the thickness of the cardiac wall, in particular the free wall of the right ventricle. Thus, stimulation and detection are all the more improved. It is also made possible to stimulate at lower energies than when the electrodes are not in direct contact with the cardiac wall.

[0024] According to one embodiment, the first branch and the second portion may each have a length of between 2 and 20 mm.

[0025] These dimensions improve the contact surface of the retaining means against the inner wall of the right ventricle and thus increase the retention of the probe through the inner wall of the right ventricle, while allowing simple and damage-free removal of the device by sustained traction.

[0026] According to one embodiment, the probe body may comprise a reinforced and elastic zone relative to the rest of the probe body, said zone being distinct from the first portion and corresponding to a folding zone of the probe.

[0027] Thus, the robustness, and therefore the lifetime of the probe, can be increased despite the bending of the probe at this point.

[0028] In addition, the elasticity of this folding zone allows automatic elastic deployment and is therefore simple to implement, as soon as the first portion of the probe is moved out of the lumen of the needle and is no longer retained against the internal wall of the lumen of the needle.

[0029] According to one embodiment, the first portion of the probe may further comprise a support means formed by a second branch which extends from the probe body in a direction oriented towards the distal end of the probe, the second branch extending from the probe body from a junction point of the probe body distinct from said second portion and the first branch.

[0030] The support means improves the retention of the probe on the heart wall by preventing involuntary migration of the probe into the ventricle after implantation of said probe. The support means in fact bears against the free external wall of the right ventricle in the implanted state of said probe.

[0031] According to one embodiment, the junction point of the second branch with the probe body may be spaced by a distance of between 1 and 30 mm from the junction point of the first branch.

[0032] These dimensions essentially correspond to the thickness of the heart wall at the level of the right ventricle. Thus, the lead is structurally configured so that the first branch and the second branch protrude from the lead body on either side of the free wall of the right ventricle in an implanted state of the lead, each of the branches allowing the lead to be retained in the heart muscle.

[0033] According to one embodiment, the probe body may comprise at least one electrode disposed between the junction point of the first branch and the junction point of the second branch.

[0034] Thus, the at least one electrode can be advantageously arranged in the thickness of the free wall of the right ventricle, which improves the stimulation of the right ventricle.

[0035] According to one embodiment, the probe may be a flexible microcable comprising an electrically conductive core coated with an electrically insulating layer, and the at least one electrode being formed by a stripped area of ​​the microcable and the diameter of the microcable being at most 1 French (0.33mm).

[0036] Thus, thanks to the dimensions of the microcable, it is possible to make the implantation of the lead less invasive. Indeed, the puncture through the cardiac tissue to introduce the microcable can be reduced to a diameter of approximately 1 French (0.33 mm). As a result, it is possible to less damage the tissues during implantation and removal of the lead.

[0037] The object of the invention is also achieved by means of an implantable flexible stimulation probe for an assembly as described above. Said probe comprises a probe body. Said probe is capable of being combined with an active implantable medical device via its proximal end and being configured to be implanted through a wall of the heart, in particular through the free wall of the right ventricle, via its distal end. Said probe comprises a first portion configured to be inserted into a needle.The first portion includes at least a first leg extending from the probe body in a direction toward the proximal end of the probe and toward the sharp free end of the needle when the first portion is inserted into the needle, the first leg extending from the probe body a predetermined distance from the distal end forming a second portion of the probe body between the first leg and the distal end of the probe.

[0038] The probe comprising at its distal end a first branch and a second portion of the probe body, said probe is thus provided with a retaining means when the probe is implanted through the free wall of the right ventricle. This means for retaining the probe is insertable into the needle by means of which it can be implanted into the cardiac tissue.

[0039] The lead being implantable through the free wall of the right ventricle, so that the first branch and the second portion of the lead body are arranged in the right ventricle, against the internal wall, the contact areas between the lead and the myocardial wall are increased, which makes it possible to improve the electrical performance of the lead.

[0040] According to one embodiment, the first portion of the probe may further comprise a support means formed by a second branch which extends from the probe body in a direction oriented towards the distal end of the probe, the second branch extending from the probe body from a junction point of the probe body which is both distinct from said second portion and from the first branch.

[0041] The support means improves the retention of the probe on the heart wall by preventing involuntary migration of the probe into the ventricle after implantation of said probe. The support means in fact bears against the free external wall of the right ventricle in the implanted state of said probe. Description des figures

[0042] The invention and its advantages will be explained in more detail in the following by means of preferred embodiments and with particular reference to the following accompanying figures, in which: There Figure 1a represents a schematic and partial view of the assembly of an implantation accessory and an implantable flexible stimulation probe according to the present invention in a non-implanted state of the probe. The Figure 1b represents a schematic and partial view of the flexible implantable stimulation probe illustrated in Figure 1a in a non-implanted state of the probe. The Figure 1c represents a schematic view of the flexible implantable stimulation probe illustrated in Figures 1a et 1b in an implanted state of the probe. The Figure 1d represents a schematic and partial view of the flexible implantable stimulation probe illustrated in Figures 1a à 1c according to a first variant. The Figure 1e represents a schematic and partial view of the flexible implantable stimulation probe illustrated in Figures 1a à 1c according to a second variant. The Figure 1f represents a schematic and partial view of the flexible implantable stimulation probe illustrated in Figures 1a à 1c according to a third variant. The Figure 2a represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2b represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2c represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2d represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2e represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2f represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2g represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2h represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2i represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2j represents a schematic view of a step in the implantation of the probe according to the present invention. The Figure 2k represents a schematic view of a step of the implantation of the probe according to the present invention.

[0043] There Figure 1a represents a schematic and partial view of the assembly 10 of an implantation accessory 11 and a flexible implantable stimulation probe 14 according to the present invention in a non-implanted state of the probe. For the sake of clarity, in the following, the elements relating to the implantation accessory 11 are described by odd references while the elements relating to the probe 14 are described with even references.

[0044] There Figure 1b representing a schematic and partial view of the flexible implantable stimulation probe 14 illustrated in Figure 1a in a non-implanted state of the probe, the Figure 1a and the Figure 1b are jointly described below.

[0045] The probe 14 comprises a probe body 16.

[0046] The probe 14 is capable of being combined with an active implantable medical device 18 via the proximal end 20 of the probe 14.

[0047] The probe 14 is configured to be implanted via the distal end 22 of the probe 14 through a wall of the heart, particularly through the free wall of the right ventricle. The distal end 22 is opposite the proximal end 20 of the probe 14.

[0048] There Figure 1c illustrates a schematic view of the implantable flexible stimulation lead 14 in an implanted state of the lead.

[0049] Elements with the same numerical references used for the description of the Figure 1a , of the Figure 1b and of the Figure 1c relate to the same elements and will not be described again in detail for each of the Figures 1a, 1b And 1c .

[0050] There Figure 1a illustrates a partial view of a needle 13 included in the implantation accessory 11 according to the present invention.

[0051] The needle 13 is provided with a free pointed puncture end 15. The free pointed puncture end 15 corresponds to the distal end of the needle 13.

[0052] The needle 13 is at least in its distal part, that is to say at least the part of the needle 13 which is illustrated in the Figure 1a , a hollow needle comprising an internal lumen 17 opening onto the free pointed puncture end 15.

[0053] The implantation accessory 11 according to the present invention also comprises a pusher means capable of being housed and sliding in the lumen 17 of the needle 13 (this pusher means is not shown in the Figures 1a à 1c ). This pusher is visible on the Figures 2c et 2d , which will be described in more detail below.

[0054] According to the present invention, a first portion 24 of the probe 14 is capable of being inserted via its distal end 22 into the internal lumen 17 of the needle 13.

[0055] There Figure 1a illustrates a state of the probe 14 in which the first portion 24 of the probe 14 is inserted into the lumen 17 of the needle 13.

[0056] Note that the height h illustrated on the Figure 1a between the needle 13 and the probe body 16 which is not inserted into the lumen 17 of the needle 13 is shown as being non-zero only for the sake of clarity for the illustration. It will be understood by those skilled in the art that for the practice of the present invention, in the state in which the first portion 24 of the probe 14 is inserted into the lumen 17 of the needle 13, the remainder of the probe body 16 extends along the outer wall 19 of the needle 13, so that there is possible, but not necessary, contact between the probe body 16 and the outer wall 19 of the needle 13.

[0057] The first portion 24 of the probe 14 comprises at least a first branch 26 which extends from the probe body 16 in a direction D oriented towards the free pointed end 15 of the needle.

[0058] The first branch 26 extends from the probe body 16 from a predetermined distance L1 from the distal end 22 of the probe 14. The portion of the probe body 16 of length L1 from the distal end 22 forms a second portion 28 of the probe body 16 disposed between the first branch 26 and the distal end 22 of the probe 14.

[0059] As illustrated in Fig. 1c, the first branch 26 and the second portion 28 of the lead 14 serve as a retaining means for holding the lead 14 across a free wall RV' of the right ventricle RV. In the implanted state of the lead 14 shown in Figure 1c , the first branch 26 and the second portion 28 of the probe 14 are arranged so as to extend longitudinally along the internal wall RV of the right ventricle RV.

[0060] As illustrated in the Figure 1b , the first branch 26 has a length l1 between a junction point 32 of the probe body 16 of the first branch 26 and the free end 26a of the first branch. The length l1 is between 2 and 20 mm.

[0061] The length L1 of the second portion 28 and the length l1 of the first branch 26 may be substantially equal to each other.

[0062] These dimensions make it possible to improve the contact surface of the retaining means against the internal wall RV" of the right ventricle RV and thus to further increase the retention of the probe 14 through the internal wall RV' of the right ventricle RV". In addition, the rigidity of the retaining means in the immediate vicinity of the junction point 32 makes it possible to generate the retention.

[0063] In one embodiment of the present invention such as that illustrated in Figures 1a à 1c , the probe body 16 may further comprise a third portion 30 which is less rigid than the first branch 26 and the second portion 28. The third portion 30 extends towards the proximal end 20 of the probe 14, i.e. towards the free pointed end 15 of the needle in the representation of the Figure 1a . The third portion 30 extends from a junction point 32 of the probe body 16 between the first branch 26 and the second portion 28, such that the first branch 26 and the second portion 28 are configured to pivot (annotated by the reference R on the Figures 1a et 1b ) integrally with each other relative to the junction point 32 of the probe body 16. The length of the third portion 30 can be adapted according to the thickness of the cardiac muscle of the targeted region.

[0064] Thus, the first branch 26 and the second portion 28 are made integral with each other during a pivoting movement R around the junction point 32. This pivoting R makes it possible to arrange the means for retaining the probe 14 against the internal wall VD of the right ventricle VD in an implanted state of the probe 14, as illustrated in Figure 1c .

[0065] As illustrated in the Figure 1a , which represents a state where the first portion 24 of the probe 14 is inserted into the lumen 17 of the needle 13, the first branch 26 and the second portion 28 form an obtuse angle O while the first branch 26 and the third portion 30 form an acute angle A. An obtuse angle is an angle whose measurement in degrees is between 90° and 180°. In particular, the obtuse angle O formed between the first branch 26 and the second portion 28 has a measurement in degrees of approximately 135°.

[0066] As described above, the first branch 26 and the second portion 28 of the probe 14 being configured to pivot integrally with one another relative to the junction point 32 of the probe body 16, the obtuse angle O between the first branch 26 and the second portion 28 of the probe 14 is preserved in the implanted state of the probe 14, as illustrated in Figure 1c .

[0067] The obtuse angle O between the first branch 26 and the second portion 28 of the probe 14 makes it possible to arrange the first branch 26 and the second portion 28 along the internal wall RV of the right ventricle RV and thus to provide a means of retaining the probe 14.

[0068] In one embodiment of the present invention such as that illustrated in Figures 1a à 1c , the first portion 26 of the probe 14 may further comprise a support means formed by a second branch 34 which extends from the probe body 16 in a direction d oriented towards the distal end 22 of the probe 14. The second branch 34 extends from the probe body 16 from a junction point 36. The junction point 36 is included in a portion of the probe body 16 which is both distinct from the second portion 28 and from the first branch 26.

[0069] In the illustrated embodiment the Figure 1a , the junction point 36 is included in the third portion 30 of the probe 14. In a variant, the junction point 36 is located on the probe body 16 beyond the third portion 30.

[0070] The second branch 34 of the probe 14 provides a support means which makes it possible to improve the retention of the probe 14 to the RV' wall of the RV right ventricle by preventing involuntary migration of the probe 14 into the RV right ventricle after implantation of the probe 14 (see Figure 1c ). The support means 34 in fact bears against the free external wall RV* of the right ventricle RV in the implanted state of the probe 14, as illustrated in Figure 1c .

[0071] As illustrated in the Figure 1b , the second branch 34 has a length l2 between a junction point 36 of the probe body 16 of the second branch 34 and the free end 34a of the second branch 34. The length l2 is between 2 and 20 mm.

[0072] The length l1 of the first branch 26 and the length l2 of the second branch 34 may be substantially equal to each other.

[0073] The junction point 36 of the second branch 34 with the probe body 14 is spaced by a length L2 of between 1 and 30 mm from the junction point 32 of the first branch 26.

[0074] These dimensions essentially correspond to the thickness of the heart wall RV' at the level of the right ventricle RV. Thus, the lead 14 is structurally configured so that the first branch 26 and the second branch 34 project from the lead body 16 on either side of the wall RV' of the right ventricle RV in the implanted state of the lead 14, each of the branches 26, 34 making it possible to retain the lead 14 to the cardiac muscle.

[0075] Since the probe 14 is a stimulation probe, it comprises at least one stimulation electrode.

[0076] In a variant, the probe 14 may also comprise at least one detection electrode.

[0077] THE Figures 1d à 1f illustrate alternative embodiments of the first portion 24 of the probe 14 comprising at least one electrode. These alternative embodiments can be combined with each other. The present invention is not limited to the alternative embodiments illustrated in Figures 1d à 1f .

[0078] Elements with the same numerical references already used for the description of the Figures 1a à 1c will not be described again in detail, and reference is made to their descriptions above.

[0079] There Figure 1d illustrates a first portion 24 which comprises only one branch 26. In this variant, the first branch 26 and the distal end 22 of the second portion 28 each comprise an electrode E1, E2.

[0080] Like the Figure 1d , there Figure 1e illustrates a first portion 24 which comprises only one branch 26. In this variant, the distal end 22 of the second portion 28 comprises an electrode E2 and the probe body 16 further comprises an electrode E3 spaced by a length L3 from the junction point 32 of the probe 14. The length L3 is between 2 and 50 mm, in particular between 2 and 30 mm.

[0081] The electrode E3 may be an E3 cathode which is preferentially located on the proximal side of the junction point 32 of the probe 14 in order to position the E3 cathode in the thickness of the cardiac muscle. Thus, there is contact of the E3 cathode with the right ventricle wall in the thickness of the RV wall rather than on the surface of the RV internal wall.

[0082] The length L3 is thus defined as the distance between the junction point 32 and the electrode E3, so as to maintain the cathode E3 in the cardiac muscle, i.e. in the thickness of the RV' wall. Indeed, the surface contacts being more subject to micro movements due to the heartbeat, it is preferable to position the cathode E3 in the thickness of the wall of the right ventricle RV'.

[0083] Thus, these dimensions allow, in an implanted state of the probe, to place the E3 electrode in the thickness of the cardiac wall, in particular the free wall of the right ventricle. As a result, stimulation is further improved.

[0084] There Figure 1f illustrates a first portion 24 which comprises a first branch 26 and a second branch 34. In this variant, the probe body 16 comprises an electrode E4 arranged between the junction point 32 of the first branch 26 and the junction point 36 of the second branch 34.

[0085] Thus, the E4 electrode can be advantageously placed in the thickness of the free wall of the right ventricle, which improves stimulation of the right ventricle.

[0086] In a variant, the retaining function of the second branch 34 can be obtained via an elastic conformation according to a radius of curvature (3 to 30 mm radius) of the lead body 16 starting at the level of the electrode E4. The advantages of this variant lie in the fact of less impact on the pericardial sac and of orienting the lead body 16 tangentially to the external wall of the muscle, a configuration less stressful for the lead body 16 (resistance to mechanical fatigue). This curvature can replace or supplement the retaining function of the second branch 34.

[0087] In another variant, the probe 14 may be provided with four electrically independent electrodes in order to optimize the stimulation / detection system for a given implantation area.

[0088] Since the stimulation electrodes are in direct contact with the heart wall, it is also possible to stimulate at lower energies.

[0089] The present invention also makes it possible to avoid having to introduce a probe into the cavity of the right ventricle for right ventricular stimulation. Implantation of the probe is thus made less invasive. The vasculature of the implanted patient is thus not altered.

[0090] Additionally, according to one embodiment, the probe may be a flexible microcable comprising an electrically conductive core coated with an electrically insulating layer, and the at least one electrode may be formed by a stripped area of ​​the microcable. In this embodiment, the diameter of the microcable is at most 1 French (0.33 mm).

[0091] Thus, thanks to the dimensions of the microcable, it is possible to make the implantation of the probe even less invasive.

[0092] The main advantage of this technique lies in its micro-invasive nature. Given the very small diameter of the probe, it is possible to use 18 to 24 gauge puncture needles, allowing for insertion by subxiphoid puncture (without the need for surgical opening requiring closure methods such as the placement of one or more sutures). In addition to faster patient recovery, the advantage of this approach is a reduction in the risk of infection.

[0093] Furthermore, the probe body 16 according to the present invention may comprise a zone 3 reinforced and elastic relative to the rest of the probe body 16. This zone 3 is distinct from the first portion 24 and corresponds to a folding zone of the probe 14, as illustrated in Figure 1a . Thus, the robustness, and therefore the lifetime of the probe 14, can be increased despite the bending of the probe at this zone 3.

[0094] The implantation of the probe 14 is further described with reference to the description of the method for implanting such a probe through a wall of the heart, in particular through the free wall of the right ventricle by means of the Figures 2a à 2k .

[0095] Elements with the same numerical references already used for the description of the Figures 1a à 1c will not be described again in detail, and reference is made to their descriptions above.

[0096] In the first step of the implantation method according to the present invention as illustrated in Figure 2a , a first portion 24 of the probe 14 is inserted into the lumen 17 of the needle 13. The probe 14 is folded at the level of the folding zone 3 as at Figure 1a previously described.

[0097] Needle 13 is punctured from the thoracic surface and then approached the wall of the right ventricle RV' in direction A.

[0098] The needle 13 is moved until the free puncture end 15 of the needle 13 punctures the wall of the right ventricle RV' as illustrated in Figure 2b .

[0099] Many guidance / tracking systems can be used: surface or transesophageal ultrasound, stimulation, anatomical surface tracking, injection of contrast agent under image intensifier. This list is not exhaustive.

[0100] While the free puncture end 15 of the needle 13 is located inside the right ventricle RV, a pusher means 21 of the implantation accessory according to the present invention pushes the first portion 24 of the probe 14 in the direction A out of the lumen 17 of the needle 13, as illustrated in Figure 2c .

[0101] There Figure 2d represents a next step in which the first portion 24 of the probe 14 is almost entirely outside the lumen 17 of the needle 13.

[0102] The pusher means 21 is then retracted in a direction B opposite to the direction A and the needle 13 is withdrawn from the wall VD' in the direction B.

[0103] So, at the stage of the Figure 2e , the first portion 24 of the probe 14 is outside the needle 13 and is in the right ventricle RV. The flexibility and elasticity of the bending zone 3 causes the probe 14 to be deployed to the configuration shown in Figure 2f , which also corresponds to that of the Figure 2b previously described.

[0104] Then, as illustrated in Figures 2g Then 2h , probe 14 is lightly pulled in direction B. Direction B extends from the inside of the right ventricle to the outside of the heart.

[0105] At the stage of the Figure 2i , the second branch 34 slides through the wall of the right ventricle VD' towards the outside of the heart in the direction B. The orientation of the second branch 24, the free end 34a of which points towards the distal end 22 of the probe 14 makes it possible to facilitate the withdrawal movement in the direction B of the second branch 24.

[0106] The free end 26a of the first branch 26 abuts against the internal wall VD" of the right ventricle VD. This abutment causes the pivoting R of the first branch 26 and of the second portion 28 of the probe 14 relative to the junction point 32 as illustrated in Figure 2i .

[0107] As illustrated in the Figure 2j , the pivoting R continues so as to pivot the first branch 26 and the second portion 28 of the probe 14 by approximately 90° relative to the initial position in the needle 13 as illustrated in the Figure 2a .

[0108] At the same time as the pivoting of the first branch 26 and the second portion 28, the probe 14 continues to be pulled in the direction B until the first branch 26 and the second portion 28 of the probe 14 come to bear against the internal wall RV" of the right ventricle CD as illustrated in Figure 2k , thus limiting the pivoting to an angle of essentially 90°.

[0109] The obtuse angle O formed between the first branch 26 and the second portion 28 makes it possible to prevent involuntary withdrawal of the probe 14 in the direction B by positioning the first branch 26 and the second portion 28 of the probe 14 in abutment against the internal wall RV" of the right ventricle CD. Indeed, when the probe 14 is pulled in the direction B, the first branch 26 and the second portion 28 of the probe 14 abut against the internal wall RV" of the right ventricle CD. This abutment prevents involuntary withdrawal of the probe 14 from the right ventricle.

[0110] The correct positioning of the probe 14 can be confirmed by the electrical performance attesting to the correct positioning of the electrodes or by an ultrasound check or under a brightness amplifier.

[0111] The second branch 34 serves as a support means, the free end 34a of the second branch 24 coming to abut against the external wall VD* of the heart.

[0112] The support means 34 makes it possible to improve the retention of the probe 14 on the RV wall of the heart by preventing involuntary migration of the probe 14 in the direction A into the RV ventricle after implantation of said probe.

Claims

1. An assembly of an implanting accessory and of a flexible implantable stimulation lead, said lead (14) comprising a lead body (16), and said lead (14) being able to be combined with an active implantable medical device via its proximal end (20) and being configured to be implanted through a heart wall, in particular through the free wall (VD') of the right ventricle (VD), via its distal end (22), the implanting accessory comprising a needle (13) with a pointed free puncturing end (15), the needle (13) being, at least in its distal part, a hollow needle comprising an inner lumen (17) opening onto the pointed free puncturing end (15), at least a first portion (24) of the lead (14) being able to be inserted via its distal end (22) into the inner lumen (17) of the needle (13), wherein : in a state where the first portion (24) of the lead (14) is inserted into the lumen (17) of the needle (13), said first portion (24) of the lead (14) comprises at least a first branch (26) that extends from the lead body (16) in a direction (D) oriented toward the pointed free end (15) of the needle (13), the first branch (26) extending from the lead body (16) from a junction point (32) arranged at a predetermined distance (L1) from the distal end (22) that forms a second portion (28) of the lead body (16) between the junction point (32) of the first branch (26) and the distal end (22) of the lead (14) ; and the lead body (16) further comprises a third portion (30) that is less rigid than said first branch (26) and the second portion (28), the third portion (30) extending toward the proximal end (20) of the lead (14) from the junction point (32) of the first branch (26), such that the first branch (26) and the second portion (28) are configured to pivot securely with one another relative to said junction point (32) in response to the free end (26a) of the first branch (26) coming to abut against the inner wall of the heart, in particular against the inner wall (VD") of the right ventricle (VD), during a removal movement of the lead (14) from the inside of the heart, in particular from the inside of the right ventricle (VD), toward the outside of the heart.

2. The assembly of claim 1, wherein, in a state where the first portion (24) of the lead (14) is inserted into the lumen (17) of the needle (13), the first branch (26) and the second portion (28) form an obtuse angle (O) and the first branch (26) and the third portion (30) form an acute angle (A).

3. The assembly of any one of the preceding claims, wherein the first branch (26) and / or the second portion (28) comprise at least one electrode (E1, E2).

4. The assembly of any one of the preceding claims, wherein the lead body (16) comprises at least one electrode (E3) that is spaced away from the junction point (32) of the lead (14) by a length (L3) of between 2 and 50 mm, in particular between 2 and 30 mm.

5. The assembly of any one of the preceding claims, wherein the first branch (26) and the second portion (28) each have a length (11, L1) of between 2 and 20 mm.

6. The assembly of any one of the preceding claims, wherein the lead body (16) comprises a zone (3) that is reinforced and elastic relative to the rest of the lead body (16), said zone (3) being different from the first portion (28) and corresponding to a bending zone (3) of the lead (14).

7. The assembly of any one of the preceding claims, wherein the first portion of the lead (24) further comprises a bearing means formed by a second branch (34) that extends from the lead body (16) in a direction (d) oriented toward the distal end (22) of the lead (14), the second branch (34) extending from the lead body (16) from a junction point (36) of the lead body (16) that is both different from said second portion (28) and from the first branch (26).

8. The assembly of claim 7, wherein the junction point (36) of the second branch (34) with the lead body (16) is spaced apart by a distance (L2) of between 1 and 30 mm from the junction point (32) of the first branch (26).

9. The assembly of claim 7 or claim 8, wherein the lead body (16) comprises at least one electrode (E4) arranged between the junction point (32) of the first branch (26) and the junction point (36) of the second branch (34).

10. The assembly of any one of the preceding claims, wherein the lead (14) is a flexible microwire comprising an electrically conductive core coated with an electrically insulating layer, and the at least one electrode (E1, E2, E3, E4) being formed by a stripped zone of the microwire and the diameter of the microwire being no more than 1 French (0.33 mm).

11. A flexible implantable stimulation lead for an assembly of any one of the preceding claims, the lead (14) comprising a lead body (16), and said lead (14) being able to be combined with an active implantable medical device via its proximal end (20) and being configured to be implanted through a heart wall, in particular through the free wall of the right ventricle, via its distal end (22), the lead (14) comprising a first portion (24) configured to be inserted into a needle of the assembly of any one of the preceding claims, the first portion (24) comprising at least a first branch (26) that extends from the lead body (16) in a direction (D) oriented toward the proximal end (20) of the lead (14) and toward the pointed free end (15) of the needle when the first portion (24) is inserted into the needle, the first branch (26) extending from the lead body (16) at a predetermined distance (L1) from the distal end (22) that forms a second portion (28) of the lead body (16) between the first branch (26) and the distal end (22) of the lead (14), wherein the lead body (16) further comprises a third portion (30) that is less rigid than said first branch (26) and the second portion (28), the third portion (30) extending toward the proximal end (20) of the lead (14) from the junction point (32) of the first branch (26) such that the first branch (26) and the second portion (28) are configured to pivot securely with one another relative to said junction point (32) in response to the free end (26a) of the first branch (26) coming to abut against the inner wall of the heart, in particular against the inner wall (VD") of the right ventricle (VD), during a removal movement of the lead (14) from the inside of the heart, in particular from the inside of the right ventricle (VD), toward the outside of the heart.

12. The flexible implantable stimulation lead of claim 11, wherein the first portion of the lead (24) further comprises a bearing means formed by a second branch (34) that extends from the lead body (16) in a direction (d) oriented toward the distal end (22) of the lead (14), the second branch (34) extending from the lead body (16) from a junction point (36) of the lead body (16) that is both different from said second portion (28) and from the first branch (26).